The American Chemical Society said U.S. pet owners spent $18.5 million last year on veterinary care, medications and other non-food pet supplies.
And as people around the world devote more of their income to keeping pets healthy and comfortable, pharmaceutical companies are devoting more research to pet health.
Writing in the ACS journal Chemical & Engineering News, Associate Editor Rachel Petkewich reported the amount of money spent on pet care in the United States is expected to grow by more than 6 percent annually. And that, she said, is spurring global pharmaceutical companies best known for making human medicines to devote more research dollars for their animal health divisions.
Such research has yielded new medicines and vaccines to keep cats and dogs healthy. For example, Petkewich cited recently approved canine diet drugs, a drug for vomiting in dogs and a new medication for the barking and other undesirable behavior associated with separation anxiety.
But Petkewich noted people might also benefit from animal health research, with products originally developed for animals often being re-purposed for diseases in humans.
Copyright 2007 by United Press International
Related stories:
PET scans lead to treatment changes in majority of colorectal cancer patients
In the largest multi-institutional study to date examining the impact of positron emission tomography (PET) in changing disease management of individuals with suspected recurrent colorectal cancer, researchers found that treatment plans were changed for more than half of patients, according to an article in the September issue of
The Journal of Nuclear Medicine.
Teamwork cuts out unnecessary biopsies, researchers find
Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer. New Saint Louis University research found that when nuclear medicine clinicians and treating physicians work together to interpret PET-CT scan results, the accuracy dramatically improves, sparring patients unnecessary pain and suffering.
Has cancer spread? Research identifies best way to find answers so treatment can begin
For patients with head and neck cancer, accurately determining how advanced the cancer is and detecting secondary cancers usually means undergoing numerous tests – until now. New Saint Louis University research has found that the PET-CT scanner can be used as a stand-alone tool to detect secondary cancers, which occur in 5 to 10 percent of head and neck cancer patients.
DNA study unlocks mystery to diverse traits in dogs
Discovery offers potential benefits for dogs and their owners
What makes a pointer point, a sheep dog herd, and a retriever retrieve? Why do Yorkshire terriers live longer than Great Danes? And how can a tiny Chihuahua possibly be related to a Great Dane?
Road pollution blamed for higher allergy risk in kids
New evidence blames traffic-related pollution for increasing the risk of allergy and atopic diseases among children by more than fifty percent. What's more, the closer children live to roads, the higher their risk.
Power of molecular imaging reveals secrets of the heart
The extraordinary action of a new cellular therapy came to light as a result of powerful PET and SPECT imaging in a recent study reported in the April issue of the
Journal of Nuclear Medicine. Researchers in Germany were able to observe the repair action of circulating progenitor cells (CPCs), immature blood-derived cells capable of developing into adult stem cells, as they successfully preserved healthy heart tissue and corrected blood flow imbalance within the heart.
PET confirmed as valuable cancer diagnostic and disease-staging tool
The recent release of data by the National Oncologic PET Registry (NOPR) showing that positron emission tomography (PET) produced scans revealing disease at a molecular level, which then caused physicians to change treatment plans for more than one-third of participating patients, has corroborated decades of nuclear medicine research.
Scans spot hidden tumors in rare cancer syndrome
Researchers at Dana-Farber Cancer Institute report that full-body PET/CT scanning detected unsuspected, treatable tumors in 3 of 15 patients with Li-Fraumeni syndrome (LFS), a rare genetic cancer syndrome for which no screening tests have been recommended.